3 / 12
Page 33
conferenceseries
.com
Volume 9
Journal of Biotechnology & Biomaterials
ISSN: 2155-952X
JOINT EVENT
February 28-March 02, 2019 | Berlin, Germany
5
th
International Conference on
Enzymology and Protein Chemistry
&
22
nd
Global Congress on
Biotechnology
Biotechnology 2019
Enzymology 2019
February 28-March 02, 2019
&
Human metaplastic breast carcinoma and decorin
Annele Sainio
University of Turku, Finland
D
ecorin is a central extracellular matrix (ECM) proteoglycan known for its oncosuppressive activity. In various types of
cancer, including breast cancer, decorin´s expression in the tumor microenvironment has been reported to be markedly
decreased. Furthermore, its reduced expression has been shown to be associated with poorer outcome in invasive breast cancer.
Metaplastic breast carcinoma (MBC) is a rare subtype of invasive breast cancer and has poor prognosis. In general, cancers
are heterogeneous cellular masses comprised of different cell types and their ECM. However, in MBC little is known about
the composition of ECM and its constituents. The aim of our study is to explore decorin immunoreactivity and the effect of
adenoviral decorin cDNA (Ad-DCN) transduction in MBC. Methods included multiple immunohistochemical stainings to
characterize the massive breast tumour. To explore the effect of Ad-DCN transduction on the tumor tissue, three-dimensional
(3D) explant cultures derived from the tumour are transduced with the modified adenovirus. The immunohistochemistry
results showed that MBC tumour was completely negative for decorin demonstrating that the malignant cells were not able
to synthesize decorin. Furthermore, Ad-DCN transduction resulted in a markedly inhibited cell proliferation and altered
cytological phenotype ofMBC explants by decreasing the amount of atypical cells.The results of our study favor the development
of novel adjuvant therapies based on decorin. Noteworthy is also the idea of “normalization of the tumour microenvironment”
whereby decorin in its part could orchestrate cancer cells towards a less malignant phenotype.
Biography
Annele Sainio obtained her Master of Science Degree in Genetics in the Department of Biology at the University of Turku (Finland), and defended her thesis “The role
of extracellular matrix macromolecules in cancer and diabetic macroangiopathy - with special reference to decorin and hyaluronan” in the spring 2016 respectively.
Currently, she works as a Postdoc in the Department of Medical Biochemistry and Genetics at the same university. Her research is focused on specific extracellular matrix
macromolecules, particularly proteoglycans and hyaluronan in various disease processes such as tumorigenesis. She has published more than 15 papers in reputed
journals.
anorsa@utu.fiAnnele Sainio, J Biotechnol Biomater 2019, Volume 9
DOI: 10.4172/2155-952X-C2-115